RePORT ⟩ RePORTER

Skip Navigation Links

Project Details

REAGENT / VECTOR CORE

Parent Project Number2P01AR050256-06

Sub-Project ID6677

Contact PI/Project LeaderVIGLIANTI, GREGORY A.

Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS

Description

Abstract Text

The overarching main objective of this Program Project is to understand the mechanisms through which autoantigen/autoantibody complexes contribute to the initiation and/or maintainence of systemic lupus erythematosus. The various projects in the Program will rely, in part, on a number of antigens, antibodies and viral vectors to carry out the proposed specific aims. The successful completion of these aims has been and will continue to be enhanced by the availability of a set of highly defined, quality controlled reagents that will be produced by this Core.

Public Health Relevance Statement

Data not available.

NIH Spending Category

Autoimmune DiseaseLupus

Project Terms

AntibodiesAntigensAutoantibodiesAutoantigensBiologicalComplexEndotoxinsGoalsIndividualNucleic AcidsQuality ControlReagentSystemic Lupus ErythematosusToll-like receptorsViral Vectorprogramssystemic autoimmune diseasevector

Details

Contact PI/ Project Leader

Name

VIGLIANTI, GREGORY A.

Title

ASSOCIATE PROFESSOR

Contact

Other PIs

Not Applicable

Program Official

Name

Contact

Email not available

Organization

Name

BOSTON UNIVERSITY MEDICAL CAMPUS

City

BOSTON

Country

UNITED STATES (US)

Department Type

Unavailable

Organization Type

Domestic Higher Education

State Code

Congressional District

Other Information

Opportunity Number

Study Section

Special Emphasis Panel[ZAR1 EHB-D (M2)]

Fiscal Year

2009

Award Notice Date

Administering Institutes or Centers

National Institute of Arthritis and Musculoskeletal and Skin Diseases

CFDA Code

DUNS Number

604483045

UEI

FBYMGMHW4X95

Project Start Date

Project End Date

Budget Start Date

22-July-2009

Budget End Date

31-October-2009

Project Funding Information for 2009

Total Funding

$130,566

Direct Costs

$80,349

Indirect Costs

$50,217

Year	Funding IC	FY Total Cost by IC
2009	National Institute of Arthritis and Musculoskeletal and Skin Diseases	$130,566

NIH Categorical SpendingClick here for more information on NIH Categorical Spending

Funding IC	FY Total Cost by IC	NIH Spending Category
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES	$44,521	Autoimmune Disease; Lupus
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES	$86,045	Autoimmune Disease; Lupus

Sub Projects

No Sub Projects information available for 2P01AR050256-06 6677

Publications

Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.

No Publications available for 2P01AR050256-06 6677

Patents

No Patents information available for 2P01AR050256-06 6677

Outcomes

The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.

No Outcomes available for 2P01AR050256-06 6677

Clinical Studies

No Clinical Studies information available for 2P01AR050256-06 6677

News and More

Section Menu